Ngaphambi kokuba uphendule umbuzo othi "kuyini ukuchazwa kwesifo somdlavuza wesifo samaphaphu?" Kubalulekile ukukhuluma ngalokho izinombolo ezichaza izinga lokusinda likusho ngempela. Okokuqala, wonke umuntu uhlukile. Izibalo zisitshela ukuthi inkambo "yokulinganisa" noma ukusinda, kodwa asitsheli lutho ngabantu abathile. Izici eziningi zingathinta ukuchazwa kwesifo somdlavuza wesifo samaphaphu.
Kuyasiza futhi ukukhumbula ukuthi izibalo zisekelwe kolwazi oluneminyaka eminingana ubudala. Njengoba izindlela ezintsha zitholakalayo, lezi zinombolo zingase zingabonakali ngokunembile lokho okushiwo yilokho okushiwo namuhla. Isibonelo, isilinganiso seminyaka emihlanu yokusinda komdlavuza wamaphaphu kubike ngo-2017 sisekelwe kubantu abaye baxilongwa ngo-2012 nangaphambilini. Ngesikhathi esifanayo, kwakukhona ukwelashwa okusha okuvunyelwe ukwelashwa komdlavuza wamaphaphu phakathi kuka-2011 no-2016, kunaneminyaka engama-40 ngaphambi kuka-2011. Kusho ukuthini lokhu ukuthi amazinga okusinda okwamanje ahluleka ukucabangela indlela umuntu ozokwenza ngayo kulindeleke ukuba kwenziwe kunoma iyiphi yalezi zelashwa ezintsha.
Kukhona ithemba eliningi kulabo abatholwa nomdlavuza wamaphaphu namuhla, kodwa ngeshwa, izibalo ozowifunda angeke zisize ekuqondeni leli themba.
Izinto Ezingathinta I-Cell Squamous I-Lung Cancer Prognosis
Ezinye zezici ezingathinta isikhathi sokuphila kanye ne-squamous cell carcinoma zifaka:
- Isiteleka somdlavuza wakho - Isandulela-sigaba se-squamous cell carcinoma (isibonelo, isigaba sokuqala 1 noma isigaba sesi-2 ) sinombono obonakalayo kangcono kunamagciwane ezayo (njengesigaba sesithathu noma isigaba 4 ). Noma kunjalo, khumbula ukuthi eziningi zemithi yomdlavuza omusha okukhulunywe ngayo ngenhla zilabo abanamaphesenti aphezulu emdlavuza wamaphaphu.
- Abadala bakho - Abantu abadala abasebasha abanomdlavuza wamaphaphu bavame ukuhlala isikhathi eside kunabantu asebekhulile abanomdlavuza wamaphaphu. Ngenkathi izibalo, abantu asebekhulile bengenzi kanye nabantu abancane abanesifo, kuyinkolelo yokuthi umdlavuza wamaphaphu awukwazi ukuphathwa kubantu abadala. Eqinisweni, ucwaningo luye lwathola ukuthi abadala asebekhulile abanomdlavuza wamaphaphu bavame ukubekezelela izidakamizwa ezifanayo ezinconywa kubantu abasha abanesifo.
- Ubulili bakho - Isikhathi sokuphila sabesifazane abanomdlavuza wamaphaphu sikhulu esigabeni ngasinye sesifo.
- Impilo yakho ejwayelekile ngesikhathi sokuxilongwa - Ukuphila ngokugcwele ngesikhathi sokuxilongwa kuhlotshaniswa nokuphila isikhathi eside, kanye nekhono elikhulu lokulwa nemithi yokwelapha engase isandise ukusinda.
- Indlela osabela ngayo ekwelapheni - Imiphumela emibi yokwelashwa njengokuhlinzwa, i- chemotherapy , ukwelashwa okuhlosiwe , imithi ye- immunotherapy , kanye nokwelashwa kwama-radiation kuhluka kubantu abahlukene futhi kunganciphisa ikhono lakho lokubekezelela ukwelashwa.
- Ezinye izimo zempilo ongase ube nazo - Ezinye izimo zezempilo, njenge- emphysema noma isifo senhliziyo zingase zinciphise isikhathi sokuphila komdlavuza wamaphaphu. Lezi zimo nezinye zingaphazamisa ezinye izindlela zokwelapha umdlavuza wamaphaphu. Isibonelo, labo abane-COPD enamandla bangase bangakwazi ukubekezelela ukulahlekelwa i-lobe yamaphaphu abo kusuka ekuhlinzeni umdlavuza wamaphaphu.
- Izinkinga zomdlavuza wamaphaphu - Izinkinga zomdlavuza wamaphaphu njengama-clots egazi kanye nama-pleural effusions, zinganciphisa isikhathi sokuphila komdlavuza wamaphaphu wamaphaphu. Kuyaphawuleka ukuthi ezinye zalezi zinkinga, njengokucindezeleka, ziyaphathwa kakhulu, futhi ukuze kuthuthukiswe isikhathi sokuphila, kubalulekile ukugxila hhayi kuphela ekuphatheni umdlavuza wamaphaphu kodwa izimo zezokwelapha ezivame ukuhambisana nomdlavuza wamaphaphu.
- Yiba nesistimu yokusekela - Izifundo zisitshela ukuthi labo abanesimiso esiqinile sokusekela umphakathi bavame ukuba nemiphumela engcono kunalabo abangenalo. Ngenxa yalesi sizathu, ukubheka amaqembu asekelo lomdlavuza wamaphaphu kanye nemiphakathi yokweseka ingathinta ukubikezela kwakho. Noma kunjalo, izinzuzo zale miphakathi zingase zihambe ngaphezu kokusekelwa yedwa. Kukhona manje abantu abaningi abaye bafunda ngezindlela ezintsha zokwelashwa kanye nokuvivinywa kwemitholampilo engekho emphakathini wabo we-oncologist, kodwa ngokufunda ngalezi zokwelapha njengengxenye yomphakathi womdlavuza wamaphaphu osebenzayo.
- Ukuba ngummeli wakho siqu - Sifunda ukuthi ukuba ngummeli wakho ekunakekelweni komdlavuza wakho kungase kungabi ngcono kuphela izinga lakho lokuphila kodwa kwenza umehluko emiphumeleni.
Izibalo
Ngaphandle kokuhluka phakathi kwabantu abahlukene, ukubikezela kungashintsha ngokuhamba kwesikhathi njengoba ukwelashwa okungcono kutholakala njengoba kuphawuliwe ekuqaleni, futhi lezo zindlela ezingcono zitholakala ngokushesha.
I-squamous cell carcinoma ingasakazeka ezihlotsheni ezihlukene njengamathambo, izigulane ezinama-adrenal, isibindi, amathumbu amancane, noma ubuchopho, futhi ukubikezelwa kwesigaba esiphezulu salolu hlobo lomdlavuza wamaphaphu akuyona into enhle. Lokho kusho ukuthi kukhona abasinde isikhathi eside ngisho nesigaba 4 somdlavuza we-squamous cell wamaphaphu, futhi ukwelashwa okusha, okufana nezidakamizwa ezithintekayo kanye ne-immunotherapy, sekuqala ukuvumela abanye abantu ukuba baphile nomdlavuza wamaphaphu njengesifo esingapheli.
Iningi lezibalo ezikhona zibukeka kuzo zonke izinhlobo zomdlavuza wesifo samangqamuzana ongewona omncane ndawonye. Kulezi zimo, ukuchazwa kwe-squamous cell carcinoma kuncane kakhulu kunalokho ku- adenocarcinoma kodwa kunethemba elikhulu kunomdlavuza omkhulu we-cell lung .
Isilinganiso seminyaka emihlanu yokusinda komdlavuza ongasona omncane wamaphaphu:
- Isigaba 1 - Amaphesenti angu-49 esiteji 1A kanye namaphesenti angu-45 esigabeni 1B
- Isigaba 2 - amaphesenti angu-30 esiteji sesi-2A nesama-30 esiteji sesi-2B
- Isigaba 3 - amaphesenti angu-14 esiteji sesithathu no-5 amaphesenti wesigaba 3B
- Isigaba 4 (iMetastatic) - cishe amaphesenti angu-1, nakuba izifundo ziphakamisa ukuthi lokhu kuyanda
Ngokusho kwesiteji, ezinye iziguli ezine-mastrase cell squamous ezingenayo imithi zingelashwa. Ngokuvamile, umdlavuza we-squamous se-metastatic awukona ukwelapha kodwa kuwukuthi ephathekayo .
Ngokwesibonelo, i-chemotherapy, ingase ithuthukise ukusinda futhi isize nezimpawu zomdlavuza wamaphaphu. Izindlela eziningi zokwelapha zihlolwa manje ezinkulingweni zemitholampilo , futhi zinikeza ithemba lokuthi i-squamous cell carcinoma yamaphutha okubikezelayo izokwenza ngcono esikhathini esizayo. I-National Cancer Institute incoma ukuthi wonke umuntu onomdlavuza wamaphaphu kufanele acabange ukuthi kungenzeka yini ukuhlolwa kwemitholampilo. Ngokuthakazelisayo, izinhlangano eziningi zomdlavuza wamaphaphu zisebenzisene ndawonye ukuze zenze isevisi yomlinganiso weklinikhi yomtholampilo wamahhala emangcwabeni wamahhala ukuthi noma ubani onomdlavuza wamaphaphu wamukelekile ukuyisebenzisa.
Ukulinganisa Isibikezelo Sakho Somuntu siqu
Uma ubheka ukubikezelwa kubalulekile ukuqaphela ukuthi wonke amagciwane e-squamous yamaphaphu amaphaphu awafani. Eqinisweni, uma kwakunabantu abangu-300 abane-squamous cell lung carcinoma ekamelweni, babezoba namagciwane angama-300 ahlukile. Umdlavuza wakho ungase ube nezici zamangqamuzana eziyokwandisa noma ukunciphisa ukubikezela kwakho ukuthi i-oncologist yakho izoxoxa nawe. Ngaphezu kwalokho, ucwaningo lufuna ezinye izindlela zokulinganisela ukuchazwa kwe-squamous cell carcinoma esekelwe ekufuneni okunjengokujikeleza amangqamuzana e-tumor atholakala ku- biopsy yamanzi nokuningi.
Uma usanda kutholakala, cishe usabesaba, futhi ukukhathazeka kancane. Sifunde ukuthi ukuzifundisa ngomdlavuza wakho, nokuziphakamisela njengengxenye yethimba lakho lokunakekelwa kwezempilo, lingadlala indima enkulu ekhwalithi yakho yokuphila.
Hlola lolu lwazi kumdlavuza we-squam cell wamaphaphu, kufaka phakathi ezinye zezokwelapha ezintsha ezisetshenziswayo.
Ngezinye izikhathi kunzima ukwazi ukuthi ungaqala kuphi. Funda ngezinyathelo zokuqala ezithatha uma uthola ukuthi unomdlavuza wamaphaphu -izinkinga ezingakusiza ukukunika amandla ohambweni lwakho.
Ngaphezu kwalokho, hlola lezi zeluleko kulokho abantu abangakwenza ngokwabo ukuthuthukisa ukusinda komdlavuza wamaphaphu .
Imithombo
I-American Cancer Society. Amanani nezinombolo ze-Cancer 2016 .
Luo, X., Zang, X., Yang, L. et al. Ukuhlaziywa Kwezithombe Ezibucayi Ngokwe-Computational Compulational Predicting Prognosis Lung Cancer Prognosis. I-Journal ye-Thoracic Oncology . 2016 Nov 4.
Qi, Y., noWin Wang. Ukubaluleka Kwemitholampilo Yokudlulisa Amaseli E-Tumor Esigulini Esimangalisa Iziguli Zengculaza. I-Cancer Biomarkers . 2016 Dec 2.